Clopidogrel vs Drospirenone: side-by-side comparison
Clopidogrel (P2Y12 receptor antagonist (antiplatelet)) and Drospirenone (Progestogen with anti-mineralocorticoid and anti-androgen activity) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Clopidogrel | Drospirenone |
|---|---|---|
| Therapeutic class | P2Y12 receptor antagonist (antiplatelet) | Progestogen with anti-mineralocorticoid and anti-androgen activity |
| CAS | 113665-84-2 | 67392-87-4 |
| ATC | B01AC04 | G03AA12 |
| Molecular weight | 321.82 g/mol | 366.49 g/mol |
| Brands with this active ingredient | 1 | 2 |
What they share
Clopidogrel and Drospirenone share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Clopidogrel acts by a different mechanism than Drospirenone, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Clopidogrel: Clopidogrel itself is inactive; the active metabolite, formed in the liver by CYP2C19 and other cytochromes, irreversibly binds the P2Y12 ADP receptor on platelets. Drospirenone: Drospirenone activates progesterone receptors to suppress ovulation and produce the contraceptive effect when combined with an estrogen.
Indications compared
Clopidogrel: Clopidogrel is approved in adults for the prevention of atherothrombotic events after recent acute coronary syndrome, recent ischaemic stroke or established peripheral arterial disease, and in patients with atrial fibril… Drospirenone: Drospirenone in combination with ethinylestradiol is approved as combined oral contraception, treatment of moderate acne in women requesting contraception, and treatment of premenstrual dysphoric disorder.
Safety profile
Clopidogrel: The main adverse effect is bleeding, ranging from minor bruising to severe gastrointestinal or intracranial haemorrhage. Drospirenone: Common adverse effects include menstrual irregularities, breast tenderness, headache, mood changes and nausea, mostly in the first 2–3 cycles.
Frequently asked questions
Is Clopidogrel better than Drospirenone? ▾
Clopidogrel and Drospirenone are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Clopidogrel and Drospirenone be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Clopidogrel
Products with Drospirenone
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.